Klaus Stöhr, director of the influenza vaccine franchises, Novartis Vaccines and Diagnostics, Cambridge, Massachusetts

Klaus Stöhr moves from the WHO to industry.

Detalles Bibliográficos
Autor principal: Gewin, Virginia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2007
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095085/
https://www.ncbi.nlm.nih.gov/pubmed/17508434
http://dx.doi.org/10.1038/nj7140-112a
_version_ 1783510594942402560
author Gewin, Virginia
author_facet Gewin, Virginia
author_sort Gewin, Virginia
collection PubMed
description Klaus Stöhr moves from the WHO to industry.
format Online
Article
Text
id pubmed-7095085
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70950852020-03-26 Klaus Stöhr, director of the influenza vaccine franchises, Novartis Vaccines and Diagnostics, Cambridge, Massachusetts Gewin, Virginia Nature Article Klaus Stöhr moves from the WHO to industry. Nature Publishing Group UK 2007-05-02 2007 /pmc/articles/PMC7095085/ /pubmed/17508434 http://dx.doi.org/10.1038/nj7140-112a Text en © Nature Publishing Group 2007 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Gewin, Virginia
Klaus Stöhr, director of the influenza vaccine franchises, Novartis Vaccines and Diagnostics, Cambridge, Massachusetts
title Klaus Stöhr, director of the influenza vaccine franchises, Novartis Vaccines and Diagnostics, Cambridge, Massachusetts
title_full Klaus Stöhr, director of the influenza vaccine franchises, Novartis Vaccines and Diagnostics, Cambridge, Massachusetts
title_fullStr Klaus Stöhr, director of the influenza vaccine franchises, Novartis Vaccines and Diagnostics, Cambridge, Massachusetts
title_full_unstemmed Klaus Stöhr, director of the influenza vaccine franchises, Novartis Vaccines and Diagnostics, Cambridge, Massachusetts
title_short Klaus Stöhr, director of the influenza vaccine franchises, Novartis Vaccines and Diagnostics, Cambridge, Massachusetts
title_sort klaus stöhr, director of the influenza vaccine franchises, novartis vaccines and diagnostics, cambridge, massachusetts
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095085/
https://www.ncbi.nlm.nih.gov/pubmed/17508434
http://dx.doi.org/10.1038/nj7140-112a
work_keys_str_mv AT gewinvirginia klausstohrdirectoroftheinfluenzavaccinefranchisesnovartisvaccinesanddiagnosticscambridgemassachusetts

Ejemplares similares